128 related articles for article (PubMed ID: 36809932)
21. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
Alenabi A; Malekinejad H
Mol Cell Biochem; 2021 Sep; 476(9):3285-3301. PubMed ID: 33886060
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
27. Effect of orexin A on apoptosis in BGC-823 gastric cancer cells via OX1R through the AKT signaling pathway.
Wen J; Zhao Y; Shen Y; Guo L
Mol Med Rep; 2015 May; 11(5):3439-44. PubMed ID: 25586545
[TBL] [Abstract][Full Text] [Related]
28. CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.
Martínez-Martínez E; Martín-Ruiz A; Martín P; Calvo V; Provencio M; García JM
Oncotarget; 2016 Oct; 7(42):68781-68791. PubMed ID: 27634891
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen species, cellular redox systems, and apoptosis.
Circu ML; Aw TY
Free Radic Biol Med; 2010 Mar; 48(6):749-62. PubMed ID: 20045723
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.
Miyato H; Kitayama J; Yamashita H; Souma D; Asakage M; Yamada J; Nagawa H
J Surg Res; 2009 Jul; 155(1):40-7. PubMed ID: 19394652
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
[TBL] [Abstract][Full Text] [Related]
32. Anti-cancer effects of selective cannabinoid agonists in pancreatic and breast cancer cells.
Turgut NH; Armagan G; Kasapligil G; Erdogan MA
Bratisl Lek Listy; 2022; 123(11):813-821. PubMed ID: 36254639
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
35. Effect of cannabinoids on neural transmission in rat gastric fundus.
Storr M; Gaffal E; Saur D; Schusdziarra V; Allescher HD
Can J Physiol Pharmacol; 2002 Jan; 80(1):67-76. PubMed ID: 11911227
[TBL] [Abstract][Full Text] [Related]
36. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
[TBL] [Abstract][Full Text] [Related]
37. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
39. Methods for the synthesis of cannabinergic ligands.
Thakur GA; Nikas SP; Duclos RI; Makriyannis A
Methods Mol Med; 2006; 123():113-48. PubMed ID: 16506405
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
